Ethicann Pharmaceuticals Inc. — Form D/A

Ethicann Pharmaceuticals Inc. of TORONTO, A6, a company, filed a Form D amendment with the SEC on 2020-10-08. The offering totals $1.5M. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Robert D AurittDirectorOntario, A6
Dwayne L LashynDirectorOntario, A6
Bruce F MacklerDirectorOntario, A6
Neil D MaruokaDirectorOntario, A6
Brandon F PriceDirectorOntario, A6
Robert D AurittExecutive OfficerOntario, A6
Ulrich D ElbenExecutive OfficerOntario, A6
Bruce F MacklerExecutive OfficerOntario, A6
Brandon F PriceExecutive OfficerOntario, A6
Robert D AurittPromoterOntario, A6
Bruce F MacklerPromoterOntario, A6
Brandon F PricePromoterOntario, A6
Brandon PriceDirectorPlantation, FL
Brandon PriceExecutive OfficerPlantation, FL
Brandon PricePromoterPlantation, FL
NEIL MARUOKADirectorBETHESDA, MD
DWAYNE LASHYNDirectorBETHESDA, MD
BRUCE MACKLERDirectorBETHESDA, MD
BRUCE MACKLERExecutive OfficerBETHESDA, MD
BRUCE MACKLERPromoterBETHESDA, MD
ULRICH ELBENExecutive OfficerONTARIO, A6
ROBERT AURITTDirectorONTARIO, A6
ROBERT AURITTExecutive OfficerONTARIO, A6
ROBERT AURITTPromoterONTARIO, A6
Ulrich D ElbenDirectorOntario, A6

Other filings by this issuer (8)

FiledFormOfferingSold
2022-05-03D$25K
2020-09-04D/A$1.0M
2020-09-03D$1.0M
2019-07-26D/A$1.5M
2019-07-12D$1.5M
2019-02-07D/A$377K$19K
2019-02-07D/A$377K$19K
2019-02-07D$377K$19K

More